# Catalyst Bancorp, Inc.: overview CLST · Nasdaq · CIK 1849867 · [Financials](/sectors/financials.md) Pages: [Overview](/companies/clst.md) · [Financials](/companies/clst/financials.md) · [Filings](/companies/clst/filings.md) · [Insiders](/companies/clst/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.11](/filings/0001104659-25-111034.md) | not reported | [0.16](/filings/0001104659-26-062126.md) | [0.14](/filings/0001104659-26-096825.md) | [0.13](/filings/0001104659-25-111034.md) | not reported | [0.15](/filings/0001104659-26-062126.md) | [0.14](/filings/0001104659-26-096825.md) | | Free cash flow | $k | [771 d](/filings/0001104659-25-111034.md) | [581 d](/filings/0001104659-26-037676.md) | [361](/filings/0001104659-26-062126.md) | [1,117 d](/filings/0001104659-26-096825.md) | [827 d](/filings/0001104659-25-111034.md) | [794 d](/filings/0001104659-26-037676.md) | [657](/filings/0001104659-26-062126.md) | [958 d](/filings/0001104659-26-096825.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | not reported | [0.04](/filings/0001558370-24-004220.md) | [0.12](/filings/0001558370-25-003964.md) | [(0.78)](/filings/0001104659-26-037676.md) | [0.56](/filings/0001104659-26-037676.md) | | Free cash flow | $k | [1,916](/filings/0001558370-23-005015.md) | [520](/filings/0001558370-24-004220.md) | [1,836](/filings/0001558370-25-003964.md) | [2,742](/filings/0001104659-26-037676.md) | [3,099](/filings/0001104659-26-037676.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/clst/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [STILWELL VALUE LLC](/funds/1397076.md) | 2026-06-30 | $6.0m | 364,085 | | Added +81,651 | | [Knott David M Jr](/funds/1892770.md) | 2026-06-30 | $3.6m | 114,000 | | New +114,000 | | [GRAHAM CAPITAL WEALTH MANAGEMENT, LLC](/funds/1907528.md) | 2026-06-30 | $3.2m | 195,939 | | Reduced −1,346 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $3.1m | 189,486 | | Reduced −654 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.1m | 68,797 | | Added +3,164 | | [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $1.0m | 61,066 | | Added +29,436 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $571.0k | 34,571 | | Added +82 | | [Montz Harcus Wealth Management LLC](/funds/1918613.md) | 2026-06-30 | $495.3k | 30,000 | | Unchanged | | [Kestra Advisory Services, LLC](/funds/1830819.md) | 2026-06-30 | $412.8k | 25,000 | | Unchanged | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $402.0k | 24,351 | | Added +135 | ## Recent filings [All 210 filings](/companies/clst/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-29 | 14:44 ET | [8-K/A](/filings/0001849867-26-000022.md) | 9.01 Financial statements and exhibits | 0001849867-26-000022 | | 2026-09-15 | 08:51 ET | [8-K](/filings/0001849867-26-000020.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001849867-26-000020 | | 2026-08-27 | 14:39 ET | [SCHEDULE 13D/A](/filings/0000921895-26-002340.md) | Ownership report, active investor, amended | 0000921895-26-002340 | | 2026-08-18 | 11:54 ET | [8-K](/filings/0001849867-26-000018.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001849867-26-000018 | | 2026-08-14 | 13:00 ET | [10-Q](/filings/0001104659-26-096825.md) | Quarterly report, period 2026-06-30 | 0001104659-26-096825 | | 2026-07-30 | 09:46 ET | [8-K](/filings/0001849867-26-000016.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001849867-26-000016 | | 2026-07-14 | 09:41 ET | [8-K](/filings/0001849867-26-000014.md) | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001849867-26-000014 | | 2026-06-26 | 10:54 ET | [8-K](/filings/0001849867-26-000011.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001849867-26-000011 | | 2026-05-21 | 11:01 ET | [8-K](/filings/0001849867-26-000009.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001849867-26-000009 | | 2026-05-15 | 11:52 ET | [10-Q](/filings/0001104659-26-062126.md) | Quarterly report, period 2026-03-31 | 0001104659-26-062126 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-037676.md), filed Mar 31, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1849867 - Tickers: CLST - Exchange: Nasdaq - SIC code: 6035 Savings Institution, Federally Chartered - State of incorporation: not reported - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 09:14 ET. No prices; not investment advice.